In a major move against high prescription costs, AstraZeneca has agreed to sell its drugs at a discount through Medicaid, marking a significant win for the Trump administration's healthcare initiative.
Conor McGregor has been suspended from the UFC for 18 months due to missed anti-doping tests. The fighter's future remains uncertain as he navigates this setback and ongoing controversies.
In a controversial military action, the U.S. killed four individuals aboard a vessel off Venezuela, claiming it was transporting illegal drugs. Defense Secretary Pete Hegseth insists such strikes will continue to protect Americans.
President Trump reveals plans for a new website, TrumpRx, aimed at providing discounted prescription medications directly to Americans, particularly benefiting low-income families. This initiative follows Pfizer's agreement to lower drug prices, promising a transformative approach to healthcare access.
President Trump is set to unveil a new strategy to lower drug costs, including the launch of a 'TrumpRx' website for discounted medications and a deal with Pfizer. This move aims to tackle high prescription prices that burden American patients.
A 5-year-old girl named Suza Kenyaba died from malaria due to critical delays in foreign aid delivery caused by U.S. policy changes, revealing a devastating health crisis in Congo.
Scientists have engineered a modified strain of Salmonella to combat cancer, showing promise in colorectal cancer treatment in mice. This innovative approach could revolutionize cancer therapies.
President Trump announces a controversial 100% tariff on foreign brand-name drugs, leaving patients and experts questioning the implications for prescription prices and U.S. manufacturing. Will your medications cost more?
Singapore's pharmaceutical companies are anxious about new U.S. tariffs on branded drugs. Deputy PM Gan Kim Yong seeks clarity on tariff exemptions as firms plan U.S. expansions. Can they remain competitive?
In a surprising announcement, President Trump declared a 100% tariff on patented pharmaceuticals unless companies manufacture in the U.S., leaving many confused about the implications for drug prices and healthcare.
